[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"arthroplasty-total-hip-replacement\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:arthroplasty-total-hip-replacement":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,48],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100652113","qlesp-block-versus-penglfcn-block-for-total-hip-arthroplasty-100652113",false,"NCT07771829","QLESP Block Versus PENG+LFCN Block for Total Hip Arthroplasty","Comparison of Ultrasound-Guided QLESP Block Versus Pericapsular Nerve Group Block Combined With Lateral Femoral Cutaneous Nerve Block on Postoperative Analgesia and Functional Recovery in Total Hip Arthroplasty: A Randomized Controlled Trial","QLESP","Inclusion Criteria:\n\n* Age 18 to 70 years\n* Scheduled for elective unilateral total hip arthroplasty via posterolateral approach\n* American Society of Anesthesiologists (ASA) physical status I-III\n* Body mass index (BMI) \\\u003C 35 kg\u002Fm²\n* Ability to understand pain scoring and patient-controlled analgesia (PCA) use\n* Willing and able to provide written informed consent\n\nExclusion Criteria:\n\n* Allergy or hypersensitivity to local anesthetics (ropivacaine)\n* Long-term opioid use or chronic pain history requiring regular analgesic use\n* Active malignancy or infection at the puncture site\n* Severe psychiatric disorders or communication barriers\n* Severe cardiopulmonary disease\n* History of opioid abuse or substance dependence\n* Participation in another interventional clinical trial within 3 months prior to enrollment\n* Coagulation abnormalities\n* Pregnancy or breastfeeding\n* Any condition that, in the investigator's opinion, would compromise patient safety or data integrity","ALL","18 Years","70 Years",{"count":21,"type":22},136,"ESTIMATED","INTERVENTIONAL",[25],"NA","Total hip arthroplasty (THA) is a common surgery to replace damaged hip joints, but many patients experience significant pain after surgery, which can delay recovery and increase the need for strong pain medications (opioids). Nerve blocks are a technique where anesthetic medication is injected near specific nerves to reduce pain. This study compares two different ultrasound-guided nerve block techniques for pain control after THA: the QLESP block (a newer technique that targets two areas with a single injection) and the PENG block combined with the LFCN block (a currently used technique that targets nerves around the hip joint and the outer thigh). Participants in this study will be randomly assigned (like a coin flip) to receive either the QLESP block or the PENG+LFCN block after surgery. The study aims to determine which nerve block provides better pain relief and reduces the need for opioid pain medications in the first 24 hours after surgery. Pain scores, recovery of leg movement, time to first walk, length of hospital stay, and any side effects will also be compared between the two groups.",[28,29],"Pain Management","Arthroplasty Total Hip Replacement",[31,32,33,34,35],"Total Hip Arthroplasty","Nerve Block","Postoperative Analgesia","QLESP Block","PENG Block","RECRUITING","2026-08-19",{"date":39,"type":40},"2026-08-20","ACTUAL",{"date":37,"type":40},{"date":43,"type":22},"2027-02-28",{"name":45,"class":46},"Huazhong University of Science and Technology","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":17,"minAge":54,"maxAge":4,"enrollmentInfo":55,"targetDuration":4,"studyType":23,"phases":57,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":5},"100620338","a-prospective-single-arm-trial-to-determine-contamination-rates-when-using-an-antibacterial-incise-drape-during-orthopedic-surgery-100620338","NCT07356323","A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery","Inclusion Criteria:\n\n* Subject is ≥ 22 years of age on the day of surgery.\n* Subject is scheduled to undergo a unilateral primary arthroplasty procedure on a hip or knee.\n* Subject is capable of providing informed consent.\n* Subject is willing and able to return for all visits.\n\nExclusion Criteria:\n\n* Subject is pregnant or lactating prior to surgery.\\*\n\n  \\*Women who have had surgical sterilization by a medically accepted method (e.g., tubal ligation, hysterectomy, or oophorectomy) or are post-menopausal, defined as not having menstruation for \\> 12 months will not be required to undergo pregnancy testing\n* Subject is scheduled to undergo a lower extremity bilateral arthroplasty procedure.\n* Subject had a previous open knee surgery on the study knee or is scheduled to undergo a revision knee arthroplasty.\n* Subject has had a previous surgery for revision femoral acetabular osteotomy or total hip arthroplasty on the study hip.\n* Subject is scheduled for lower extremity arthroplasty due to trauma.\n* Subject was previously diagnosed with septic arthritis or has a history of infection in the joint.\n* Subject has taken any antibiotics within 4 weeks before surgery.\n* Subject has an allergy or sensitivity to components of the device (e.g., chlorhexidine gluconate or acrylate-based adhesive).\n* Subject is currently enrolled in another trial.","22 Years",{"count":56,"type":22},179,[25],"The goal of this clinical study is to generate data on the intended use of a chlorhexidine gluconate (CHG)-impregnated antimicrobial incise drape. The study includes subjects undergoing primary hip or knee arthroplasty procedures.\n\nThe study evaluates the intraoperative performance and safety of the incise drape during surgery, including assessment of contamination and operative characteristics.\n\nParticipants will have a CHG-impregnated antimicrobial incise drape applied during their surgical procedure. During surgery, samples will be collected from the operative site to assess potential bacterial contamination.",[60,29],"Arthroplasty Replacement, Knee",[62,63,64,65],"Chlorohexidine Gluconate","Incise drape","CHG","Ioban","2026-06-29",{"date":68,"type":40},"2026-07-01",{"date":70,"type":40},"2026-02-19",{"date":72,"type":22},"2026-10",{"name":74,"class":75},"Solventum US LLC","INDUSTRY"]